ABSTRACT Background Respiratory syncytial virus (RSV) is increasingly recognized as a trigger for adverse outcomes in older adults with heart failure (HF). Following FDA approval of RSV vaccines for adults ≥ 60 years in 2023, real‐world evidence in HF populations remains limited. Methods We conducted a multicenter retr...
Allahdad Khan, M. R. Shabbir, Jamil Nasrallah et al.· Clinical Cardiology· 0 citations
BACKGROUND
Type 2 diabetes is associated with a high risk of heart failure. Hence, precise cardiac imaging can help early detection of subclinical myocardial dysfunction. We investigated the associations of glycemic status and markers with left ventricular (LV) remodeling assessed by cardiac magnetic resonance imaging...
Arnaud D. Kazé, C. Ani, Ervin R. Fox et al.· Journal of the American Hear...· 0 citations
In ambulatory patients with HFrEF receiving contemporary GDMT, it is not convincing evidence that the neutral effect of vericiguat on cardiovascular death or first HF hospitalization was modified by GDMT class, dose attainment, or overall intensity, in a cohort with very high background GDMT use and limited power for i...
Justin A. Ezekowitz, J. Butler, Derek Cyr et al.· European Journal of Heart Fa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.